SAO PAULO (Reuters) – Shareholders of Brazilian healthcare operator Hapvida approved a change to the company’s bylaws that will force any shareholder or group of shareholders with a stake larger than 20% to launch a tender offer for all remaining shares. The mechanism, known as a “poison pill,” was approved by a majority of Hapvida […]
Health
Brazil’s Hapvida shareholders approve adding ‘poison pill’ to bylaws
Audio By Carbonatix
SAO PAULO (Reuters) – Shareholders of Brazilian healthcare operator Hapvida approved a change to the company’s bylaws that will force any shareholder or group of shareholders with a stake larger than 20% to launch a tender offer for all remaining shares.
The mechanism, known as a “poison pill,” was approved by a majority of Hapvida shareholders in a general meeting on Tuesday, according to the meeting minutes.
(Reporting by Andre Romani; Editing by Leslie Adler)